110 related articles for article (PubMed ID: 6958365)
1. Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
Sobrero A; Muzzulini C; D'Amore F; Bogliolo G; Massa G; Ghio R; Pannacciulli I
Cancer Treat Rep; 1982 Dec; 66(12):2061-70. PubMed ID: 6958365
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin.
Massa G; Bogliolo G; D'Amore F; Muzzulini C; Ghio R; Pannacciulli I
J Natl Cancer Inst; 1982 Jun; 68(6):971-6. PubMed ID: 6953276
[TBL] [Abstract][Full Text] [Related]
3. Activity of doxorubicin linked to poly-L-aspartic acid on normal murine hematopoietic progenitor cells.
Bogliolo G; Muzzulini C; Lerza R; Pannacciulli I
Cancer Treat Rep; 1986 Nov; 70(11):1275-81. PubMed ID: 3768872
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of dose and schedule on normal murine hematopoietic progenitor cells following the administration of 4'-deoxydoxorubicin.
Pannacciulli I; Muzzulini C; Massa G; Bogliolo G
Br J Cancer; 1984 Nov; 50(5):647-56. PubMed ID: 6498062
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
[TBL] [Abstract][Full Text] [Related]
6. Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.
Huybrechts M; Symann M; Trouet A
Cancer Res; 1979 Sep; 39(9):3738-43. PubMed ID: 476697
[TBL] [Abstract][Full Text] [Related]
7. [Behaviour of bone marrow and splenic hemopoietic stem cells following administration of anthracyclines].
Massa G; Bogliolo G; Ghio R; Muzzulini C; D'Amore F
Boll Soc Ital Biol Sper; 1981 Jun; 57(12):1311-5. PubMed ID: 6945864
[TBL] [Abstract][Full Text] [Related]
8. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
10. Pool size of pluripotential hematopoietic stem cells increased in continuous bone marrow culture by Friend spleen focus-forming virus.
Greenberger JS; Hoffman N; Lieberman M; Botnick LE; Sakakeeny MA; Eckner RJ
J Natl Cancer Inst; 1983 Feb; 70(2):323-31. PubMed ID: 6571939
[TBL] [Abstract][Full Text] [Related]
11. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Slavin S; Seidel HJ
Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
[TBL] [Abstract][Full Text] [Related]
12. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction.
Inoue T; Hirabayashi Y; Mitsui H; Sasaki H; Cronkite EP; Bullis JE; Bond VP; Yoshida K
Exp Hematol; 1995 Nov; 23(12):1296-300. PubMed ID: 7589285
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
Marsh JC
Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
[TBL] [Abstract][Full Text] [Related]
16. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
17. Effect of prolonged expansion of marrow progenitor compartments following doxorubicin (ADR) on subsequent radiation tolerance.
Kovacs CJ; Johnke RM; Emma DA; Scarantino CW
Exp Hematol; 1985; 13 Suppl 16():89-94. PubMed ID: 3987840
[TBL] [Abstract][Full Text] [Related]
18. Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy.
de Haan G; Engel C; Dontje B; Loeffler M; Nijhof W
Cancer Res; 1995 Jan; 55(2):324-9. PubMed ID: 7529132
[TBL] [Abstract][Full Text] [Related]
19. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
